<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000662469"><TermName>ABVE</TermName><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes  the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, and etoposide. Also called ABVE regimen, DBVE,  and DBVE regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>ABVE</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa con radioterapia para tratar el linfoma de Hodgkin infantil. Incluye los medicamentos clorhidrato de doxorrubicina (Adriamycin), sulfato de bleomicina, sulfato de vincristina y etopósido. También se llama DBVE, régimen ABVE,  y régimen DBVE.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-05-26</DateFirstPublished><DateLastModified>2010-09-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000681132">ABVE</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
